31 related articles for article (PubMed ID: 10436194)
1. Diffuse Bone Uptake of 131 I and Effect on Blood Counts in a Patient With Papillary Thyroid Carcinoma and Chronic Lymphocytic Leukemia.
Latgé A; Krim M; Vija L; Ysebaert L; Zerdoud S
Clin Nucl Med; 2024 Apr; 49(4):340-341. PubMed ID: 38377372
[TBL] [Abstract][Full Text] [Related]
2. The influence of stimulated thyroglobulin and lymphocyte subsets before radioiodine therapy on the therapeutic response in patients with intermediate- and high-risk papillary thyroid carcinoma.
Lu C; Wang C; Li F; Liu X; Wang G; Li J; Wang Z; Han N; Zhang Y; Si Z; Wang X
Clin Exp Med; 2023 Oct; 23(6):2193-2200. PubMed ID: 36348126
[TBL] [Abstract][Full Text] [Related]
3. Effects of Dosimetrically Guided I-131 Therapy on Hematopoiesis in Patients With Differentiated Thyroid Cancer.
Bikas A; Schneider M; Desale S; Atkins F; Mete M; Burman KD; Wartofsky L; Van Nostrand D
J Clin Endocrinol Metab; 2016 Apr; 101(4):1762-9. PubMed ID: 26900639
[TBL] [Abstract][Full Text] [Related]
4. Effect of photopheresis on lymphocyte population in children with newly diagnosed type 1 diabetes.
Ernerudh J; Ludvigsson J; Berlin G; Samuelsson U
Clin Diagn Lab Immunol; 2004 Sep; 11(5):856-61. PubMed ID: 15358643
[TBL] [Abstract][Full Text] [Related]
5. Initial Testing of an Approximated, Fast Calculation Procedure for Personalized Dosimetry in Radionuclide Therapy Based on Planar Whole-Body Scan and Monte-Carlo Specific Dose Rates from the
Bianco D; Nappi C; Piscopo L; Volpe F; Manganelli M; Volpicelli F; Loffredo F; Totaro P; Quarto M; Cuocolo A; Klain M
Life (Basel); 2022 Aug; 12(9):. PubMed ID: 36143340
[TBL] [Abstract][Full Text] [Related]
6. Effect of ¹³¹I Therapy on Complete Blood Count in Patients with Differentiated Thyroid Cancer.
Rui Z; Wu R; Zheng W; Wang X; Meng Z; Tan J
Med Sci Monit; 2021 Feb; 27():e929590. PubMed ID: 33568620
[TBL] [Abstract][Full Text] [Related]
7. Blood cells in thyroid cancer patients: a possible influence of apoptosis.
Vrndic OB; Djurdjevic PM; Jovanovic DD; Mijatovic Teodorovic LC; Kostic IR; Jeftic ID; Zivancevic Simonovic ST
Open Med (Wars); 2016; 11(1):87-92. PubMed ID: 28352773
[TBL] [Abstract][Full Text] [Related]
8. Radioiodine Treatment and Thyroid Hormone Suppression Therapy for Differentiated Thyroid Carcinoma: Adverse Effects Support the Trend toward Less Aggressive Treatment for Low-Risk Patients.
Klein Hesselink EN; Links TP
Eur Thyroid J; 2015 Jun; 4(2):82-92. PubMed ID: 26279993
[TBL] [Abstract][Full Text] [Related]
9. Blood lymphocyte blastogenesis in patients with thyroid dysfunction: ex vivo response to mitogen activation and cyclosporin A.
Papaioannou G; Michelis FV; Papamichael K; Karga H; Tiligada E
Inflamm Res; 2011 Mar; 60(3):265-70. PubMed ID: 20972816
[TBL] [Abstract][Full Text] [Related]
10. Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer.
Lind P; Kohlfürst S
Semin Nucl Med; 2006 Jul; 36(3):194-205. PubMed ID: 16762610
[TBL] [Abstract][Full Text] [Related]
11. [Postoperative radioiodine ablation in patients with low risk differentiated thyroid carcinoma].
Díez JJ; Grande E; Iglesias P
Med Clin (Barc); 2015 Jan; 144(1):35-41. PubMed ID: 24613061
[TBL] [Abstract][Full Text] [Related]
12. Radioiodine-induced changes in lymphocyte subsets in patients with differentiated thyroid carcinoma.
Tofani A; Sciuto R; Cioffi RP; Pasqualoni R; Rea S; Festa A; Gandolfo GM; Arista MC; Maini CL
Eur J Nucl Med; 1999 Aug; 26(8):824-9. PubMed ID: 10436194
[TBL] [Abstract][Full Text] [Related]
13. Follow-up regimen of differentiated thyroid carcinoma in thyroidectomized patients after thyroid hormone withdrawal.
Oyen WJ; Verhagen C; Saris E; van den Broek WJ; Pieters GF; Corsten FH
J Nucl Med; 2000 Apr; 41(4):643-6. PubMed ID: 10768565
[TBL] [Abstract][Full Text] [Related]
14. Predicting the efficacy of first iodine-131 treatment in differentiated thyroid carcinoma.
Muratet JP; Giraud P; Daver A; Minier JF; Gamelin E; Larra F
J Nucl Med; 1997 Sep; 38(9):1362-8. PubMed ID: 9293788
[TBL] [Abstract][Full Text] [Related]
15. Sensitivity of 123I whole-body scan and thyroglobulin in the detection of metastases or recurrent differentiated thyroid cancer.
de Geus-Oei LF; Oei HY; Hennemann G; Krenning EP
Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):768-74. PubMed ID: 12029550
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
